Takeda Pharmaceuticals U.S.A. Inc. recently welcomed Catherine Pugh, the mayor of Baltimore, to its Chicago office to celebrate Black History Month. Read More »

Sandoz, a Novartis Division, recently announced plans to double sales in Japan over the 2015 to 2022 period as part of a grander, longterm strategy to deliver better access to high quality medicines to the nation. Read More »

Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »

Mark Jackson has been appointed vice president of Quality for Noven Pharmaceuticals Inc. Read More »

Spartanburg County, South Carolina has received a donation of opioid antidote.  Read More »

RXi Pharmaceuticals Corp. has named Dr. Rolf Kiessling, professor in experimental oncology at Karolinska Institutet, to its Scientific Advisory Board. Read More »

"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »

Lifes2good's new Berkeley Life Heart Health supplement, distributed by L2G North America Inc., is now available at Vitamin Shoppe and GNC stores across the country. Read More »

High prescription drug costs mean approximately 45 million adults in the U.S., or 18 percent of Americans over the age of 18, did not fill a prescription last year, according to the nonprofit group Prescription Justice.. Read More »

Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York. Read More »

The U.S. Food and Drug Administration approved Amgen's Parsabiv for the treating of secondary hyperparathyroidism in adults with chronic kidney failure and is administered at dialysis locations throughout the country. Read More »

Portola Pharmaceuticals cleared a U.S. Food and Drug Administration mid-cycle review for its new drug Betrixaban, meaning the drug will not have to go before an advisory committee at this stage. Read More »

A U.S. appeals court suspended a permanent injunction on Praluent, a cholesterol management drug, allowing Regeneron Pharmaceuticals to once again manufacture, market, sell and ship the drug around the world. Read More »

The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »

PharmaSmart International, a specialist in blood pressure kiosks, announced that its machines meet new Centers for Disease Control guidelines. Read More »

Soem critics argue that decades of U.S. Food and Drug Administration safeguards could be in jeopardy with President Donald Trump’s pick for head of the FDA. Read More »

The listed price for brand-name drugs increased 11 percent last year, but the largest pharmacy benefits manager in the U.S. said it shielded employers it works with from the bulk of that increase. Read More »

Pharmaceutical companies, trial lawyers and tort reform advocates are closely following a case that the U.S. Supreme Court has taken up that addresses the issue of plaintiffs joining suits in other states. Read More »

The sPCMA Business Forum will be held March 8-9, providing valuable information into specialty drug benefit management, specialty pharmacies, drug manufacturers and related topics.  Read More »

Eli Lilly & Co. has updated the label of Trulicity, a drug used to help control Type 2 diabetes, to state that the drug may be used in combination with insulin. Read More »